Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 30 December 2025
Accepted: 5 March 2026
First Online: 23 March 2026
Declarations
:
: JFT reports scientific adboard participation for Gilead, Biomerieux, Advanz, Menarini; lectures in symposia for Pfizer, Merck, Shionogi, Advanz, Biomerieux, Mundipharma, Gilead unrelated to the submitted article. No other conflict of interest to declare. OJB reports no competing interest that could compromise his independence regarding the present editorial. Competing interests unrelated to the editorial: consultant for Baxter, Vantive, BBraun, Fresenius medical care, and Jafron. HB had nothing to disclose.
: Not applicable.
Free to read: This content has been made available to all.
